From Biobanks to Breakthroughs: The Role of Data Curation in Drug Innovation

In modern drug discovery, data is both the greatest asset and the biggest bottleneck. Vast biobanks containing clinical, genomic, and real-world health data promise breakthroughs, yet inconsistent formats, missing values, and poor standardization often slow progress. Just as cluttered storage delays finding what matters, poorly curated data limits the power of advanced tools like artificial intelligence and machine learning. Effective data housekeeping—systematic cleaning, harmonization, and governance of health data—transforms raw information into actionable insight. High-quality, well-structured datasets reduce false signals, improve reproducibility, and increase the likelihood that promising drug candidates succeed in clinical trials. Adopting FAIR principles (Findable, Accessible, Interoperable, Reusable) ensures data can be reliably shared and reused across studies, institutions, and technologies. By aligning industry and academia around robust data strategies, the pharmaceutical ecosystem can shorten development timelines, reduce costly trial failures, and ultimately deliver safer, more effective therapies to patients faster.

Source : https://www.news-medical.net/health/Accelerating-Drug-Discovery-and-Development-with-Effective-Data-Housekeeping.aspx